Facts
as of Nov 20, 2026
Noema Pharma is a biotech company developing therapies for the most disabling symptoms of orphan conditions of the brain and nervous system. Its research and development focuses on understanding and meeting patient needs across orphan and broader neurology indications, and it hires a director of regulatory affairs. The company is headquartered in Basel, Switzerland.
It is hiring: 1 open role, 0 of them posted in the last 30 days.
- Headquarters
- Basel, Switzerland
- Founded
- 2019
- Employees
- 11-50estimated range
- Open roles
- 1Alion job postings
As of Nov 20, 2026, Alion lists 1 open role at Noema Pharma. Noema Pharma is headquartered in Basel, Switzerland. It was founded in 2019. The latest round is Series B of $115.4M, announced in 2023.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
Noema Pharma has $115.4M paid in by investors, lenders and donors.
Money innewest first
Equity raised
Nov 2024 · Series B
not statedPaid
Equity raised
Mar 2023 · Series B
$115.4MPaid
Money by yearUSD, rounds and grants
2024-1 record
2023$115.4M1 record
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
Sources name Gilde Healthcare, Jeito Capital, Forbion among the owners or investors of Noema Pharma.
Named investors, no share stated5
Holders and shares as each register or filing states them.
Noema Pharma has 6 clinical trials on record, 2 under way.
top 8%Web presenceof 133.2M domains by links, Common Crawl
Clinical trials
Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
phase 2 · under way · 164 participants · Tourette Syndrome
Sep 2024
A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause
phase 2 · completed · 40 participants · Menopause Syndrome; Menopause; Hot Flashes
Apr 2024
A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)
phase 2 · completed · 75 participants · Childhood-Onset Fluency Disorder
Jul 2022
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
Lists and programmes
Hurun Global Cheetahs
2024 · BioTech
Sources: the outlets named on each headline, each story once
What the registers and the postings say about this employer.
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Hiring slowly: few roles were posted lately.
Biotech is the largest family, 100 of open roles.
0%Remote roles0 of 1
1Hiring offices
Can they hire you from United States?by your location
Likely
1 open roles are in your country: you apply locally, no move needed.
United States1On site
Remote, from elsewhere0Rare
No posting offers visa sponsorship. Remote roles: 0.
Alion signals0-100
Demand18
Pay0
Your chance46
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time
Sep 14This week
Open roles a week: 1 then, 1 now
Where the openings areshare of open roles · trend
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
Footprint
Hiring in 1 city in 1 country.
Source: office addresses in postings and company registers